US · Healthcare · Biotechnology
EPS came in at -0.07 against a street estimate of -0.14 — a beat of 50.0%.
with an average price target of $8.67.
| Fund | Stake |
|---|---|
| HHG PLC | 5.22% |
| Hillhouse Capital Advisors, Ltd. | 5.17% |
| Morgan Stanley - Brokerage Accounts | 3.32% |
| Siren, L.L.C. | 2.59% |
| AIHC Capital Management Limited | 2.49% |
| Point72 Asset Management, L.P. | 1.20% |
| Candriam Luxembourg S.C.A. | 0.98% |
| Adage Capital Partners Gp LLC | 0.86% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NovaBridge Biosciences — free to start.
Google PlayApp StoreData updated 2026-09-18.